Company

Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients.

 Untitled ‭[1]‬

April 24, 2017

Fresenius Kabi to strengthen and diversify product portfolio by acquiring Akorn and Merck KGaA’s biosimilars business


read more
April 4, 2017

Award as “Great Place to Work” in the Dominican Republic


Read More
April 3, 2017

Representative of the U.S. Congress visits the Maricao plant in Puerto Rico


read more
March 20, 2017

Fresenius Kabi welcomes Portuguese Minister of Health


Read More
March 10, 2017

Fresenius Kabi builds new warehouse at Blonie production site


read more
February 22, 2017

Fresenius reports 13th consecutive record year and targets continued strong growth


Read More
December 21, 2016

Fresenius Kabi Germany supports Blindeninstitut Thüringen (Thuringia Institute for the Blind) with Christmas donation


read more
October 27, 2016

Fresenius: Continued strong sales and earnings growth; Lower end of Group earnings guidance raised


read more
October 12, 2016

Fresenius Kabi wins award for nutritional therapy website


read more
September 22, 2016

"I want to help others, so they won’t give up" – Living on parenteral nutrition


read more